Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura

Adrien Picod,Paul Coppo

Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura

2019

Adrien Picod
Paul Coppo

ABSTRACTIntroduction: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a life-threatening disease characterized by a severe functional deficit in the von-Willebrand cleaving protease A...

Keywords:

Thrombotic thrombocytopenic purpura
Diabetes mellitus
Immunology
Medicine
Immune system
Rituximab
Caplacizumab
ADAMTS13
Thrombotic microangiopathy
Von Willebrand factor
Plasmapheresis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

105

References

Citations